PIMA541944
Ficlatuzumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541944-Each-of-1 | In Stock | ₹ 45,790.50 |
PIMA541944 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 45,790.50
GST (18%): ₹ 8,242.29
Total Price: ₹ 54,032.79
Antigen
Ficlatuzumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
AV-299; SCH 900105
Immunogen
Human HGF
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
3.51 mg/mL
Formulation
PBS with no preservative; pH 7.5
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG1 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Ficlatuzumab has been used in trials studying the treatment of Acute Myeloid Leukemia, Non-small Cell Lung Cancer, Mullerian Mixed Tumor of Ovary, Relapsed Acute Myeloid Leukemia, and Refractory Acute Myeloid Leukemia, among others.
Compare Similar Items
Show Difference
Antigen: Ficlatuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AV-299; SCH 900105
Immunogen: Human HGF
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.51 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Ficlatuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AV-299; SCH 900105
Immunogen:
Human HGF
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.51 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Ixekizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: LY2439821
Immunogen: Human IL17A
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.15 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Ixekizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
LY2439821
Immunogen:
Human IL17A
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.15 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Narnatumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: IMC RON-8; RON8
Immunogen: Human MST1R/CD136
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.11 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Narnatumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
IMC RON-8; RON8
Immunogen:
Human MST1R/CD136
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.11 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Pateclizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: MLTA3698A; PRO283698; RG7416
Immunogen: Human LTA/TNFSF1
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.74 mg/mL
Formulation: PBS with no preservative, pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Pateclizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
MLTA3698A; PRO283698; RG7416
Immunogen:
Human LTA/TNFSF1
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.74 mg/mL
Formulation:
PBS with no preservative, pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ